Injection technique is part of device performance
A technically capable pen can still produce poor real-world outcomes when the use process is misunderstood or inconsistently performed.
What the research found
A multicenter observational study in Xi’an identified continuing gaps between recommended and actual insulin-injection behavior. The analysis associated lower lipohypertrophy incidence with factors including shorter needles, single needle use, priming and correct site rotation.
Connection to Penacta
OEM customization must not stop at color and logo. Instructions, dose-window legibility, feedback and packaging should support the intended sequence and be evaluated with representative users.
Technique depends on the device that is actually in the user’s hand, so the 60-unit disposable and the 80-unit reusable are described with the interface and increment they document, never with a general claim about pens.
Research basis
Insulin Injection Technique and Related Complications in Patients With Diabetes. PMID 39494480.Sources reviewed
Peer reviewed records used to frame the article and its limitations
Map the complete use sequence
Bring device, packaging and instructions into one human-factors plan.
Discuss use-related risks →